Pagina 27 - U.S. Pharmaceuticals & Biotech azioni - Maggiori rialzi di oggi

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

AGGIORNATO Jun 15, 2026

Esplora i U.S. (NYSE e NASDAQ) Top Gainers di oggi. Questi Pharmaceuticals & Biotech Stocks hanno registrato il maggior incremento di Market Cap rispetto al giorno di negoziazione precedente.

712 aziende

Azienda	Ultimo prezzo	Ritorno 1D	Ritorno a 1 anno	Cap. di mercato	Obiettivo degli analisti	Valutazione	Crescita	Rendimento del dividendo
XNCR	US$12.21	-1.0%	34.9%	US$914.2m	US$28.50	9.3	6.2%	n/a
GLSI	US$23.41	-2.7%	154.5%	US$353.2m	US$47.50	65.2	n/a	n/a
GLUE	US$18.12	-0.6%	275.9%	US$1.5b	US$32.33	35.6	-10.5%	n/a
INDV	US$38.40	-0.2%	170.8%	US$4.7b	US$51.50	18.6	13.8%	0%
PCRX	US$22.74	-1.1%	-6.6%	US$904.6m	US$29.67	174.1	32.8%	n/a
LCTX	US$1.23	-3.1%	42.2%	US$316.6m	US$5.50	20.7	72.3%	n/a
IRD	US$3.92	-3.1%	315.9%	US$328.8m	US$10.47	26.6	54.4%	n/a
QGEN	US$37.01	-0.1%	-25.9%	US$7.7b	US$43.82	19.0	12.4%	6.5%
ANRO	US$21.17	-1.4%	816.5%	US$753.5m	US$35.13	3.1	-1.9%	n/a
ELDN	US$3.43	-3.9%	22.5%	US$276.0m	US$8.20	2.6	-7.0%	n/a
AVBP	US$30.30	-0.8%	19.2%	US$1.4b	US$43.64	4.4	50.4%	n/a
AVIR	US$4.35	-3.1%	36.4%	US$359.3m	US$8.67	1.5	7.2%	n/a
ANNX	US$4.64	-1.5%	90.2%	US$771.7m	US$13.13	3.7	63.0%	n/a
CRMD	US$8.59	-1.7%	-38.4%	US$685.7m	US$15.20	3.7	-4.5%	n/a
CAMP	US$3.96	-5.5%	173.1%	US$217.6m	US$7.92	52.3	-0.07%	n/a
PBYI	US$7.07	-3.5%	104.9%	US$373.1m	US$5.00	14.8	-49.9%	n/a
ENTA	US$11.44	-3.9%	57.1%	US$346.0m	US$20.14	4.8	23.9%	n/a
COLL	US$34.19	-1.3%	15.1%	US$1.1b	US$54.33	14.8	41.9%	n/a
CELC	US$88.24	-0.4%	608.2%	US$4.3b	US$161.09	80.4	66.3%	n/a
LAB	US$0.85	-4.4%	-22.9%	US$346.5m	US$1.55	3.8	-6.7%	n/a
VOR	US$14.07	-2.0%	217.3%	US$778.1m	US$37.88	-0.9	47.5%	n/a
AUTL	US$1.50	-3.8%	-26.8%	US$415.2m	US$8.71	4.3	45.8%	n/a
HRMY	US$34.18	-0.8%	5.3%	US$2.0b	US$44.36	13.6	18.2%	n/a
TBPH	US$16.32	-1.9%	51.8%	US$857.8m	US$17.40	7.3	-19.2%	n/a

Page 27 of 30